Investing Profile

Gurdane Bhutani

InvestorVCFounder
Co-founder & Chief Operating Officer at MBX Capital
mbxcapital.comNew York, New York
Photo of Gurdane Bhutani, MBX Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Morgan Stanley Network
235 CONNECTIONS
Yale University Network
182 CONNECTIONS
Bain & Company Network
157 CONNECTIONS
Duke University Network
126 CONNECTIONS
Kauffman Fellows Network
109 CONNECTIONS
cb
$100K - $5.0M
$1.5M
4
CompanyStageDateRound SizeTotal Raised
Contraline
Series ANov 2022$7M
Series AOct 2021$11M
$24M
Co-investors: Jason Calacanis (Sequoia Capital), Ramtin Naimi (Abstract Ventures), Cyan Banister (Long Journey Ventures), Jaffray Woodriff, Bill Smith
Freedom Biosciences
SeedAug 2022$11M
$11M
Co-investors: Mack Luby (Mystic Ventures), Andy Coravos
Luna
Series BJun 2022
Co-investors: Sebastian Caliri (8VC)
Member, Board of Directors Contraline, Inc.Present
Instructor Cleveland ClinicPresent
Co-founder & COO FundRxPresent
Guest Lecturer The Wharton SchoolPresent
Observer, Board of Directors EmbryomePresent
Observer, Board of Directors Persist AIPresent
Lecturer Yale School of ManagementPresent
Member, Board of Directors Junction HealthPresent
Observer, Board of Directors VivodynePresent
Observer, Board of Directors ThesisPresent
Co-founder & Managing Partner MBX CapitalPresent
Fellow Kauffman FellowsPresent
Observer, Board of Directors CareRevPresent
Observer, Board of Directors Freedom BiosciencesPresent
Observer, Board of Directors Atlas HealthPresent
Instructor Cleveland Clinic Lerner College of MedicinePresent
Co-founder & Chief Operating Officer MBX CapitalPresent
Associate Bain & CompanyPresent
Summer Analyst Morgan StanleyPresent
Member, Board of Directors Ancilia BiosciencesPresent
Co-founder & President/CBO Stealth Company (Gurdane Singh Bhutani)Present
Member, Board of Directors ContralinePresent
Yale University MPH Epidemiology & Environmental Health Sciences
Duke University AB Computer Science; AB, Public Policy; Minor, Economics